Will there be bleeding symptoms after percutaneous interventional treatment of lung cancer? Generally not

Percutaneous treatment of lung cancer generally does not cause bleeding. However, if the patient's coagulation function is poor or the tumor is close to the blood vessels, it may cause bleeding.

We know that lung cancer is a very terrible disease that can cause patients to lose their lives at any time, and it needs to be treated early. So, will there be bleeding symptoms after percutaneous interventional treatment of lung cancer? Let's find out.
Generally speaking, it is not common for lung cancer patients to experience bleeding during percutaneous interventional treatment. In fact, the ablation needle used in the process of interventional treatment has the effect of stopping bleeding, so it can stop bleeding during surgical treatment.
However, if the patient's physical fitness is poor, such as coagulation dysfunction and other adverse symptoms, it is possible that bleeding symptoms may occur. In addition, if the patient's tumor is located close to blood vessels, it may also cause bleeding.
If the adverse symptoms of bleeding are lower than this, it is recommended that patients can take some common hemostatic drugs to stop bleeding. If these hemostatic drugs do not achieve a good therapeutic effect, then embolization therapy can also be performed through vascular intervention. This method of blocking the bleeding artery can also achieve effective hemostasis.
However, if these treatments are still ineffective, then thoracic surgery can be used to stop the bleeding.